Table of Content

1 Oncology Therapeutic Drug Market Overview
1.1 Product Overview and Scope of Oncology Therapeutic Drug
1.2 Oncology Therapeutic Drug Segment by Type
1.2.1 Global Oncology Therapeutic Drug Market Value Comparison by Type (2024-2034)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy
1.2.6 Others
1.3 Oncology Therapeutic Drug Segment by Application
1.3.1 Global Oncology Therapeutic Drug Market Value by Application: (2024-2034)
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory and Lung Cancer
1.3.6 Others
1.4 Global Oncology Therapeutic Drug Market Size Estimates and Forecasts
1.4.1 Global Oncology Therapeutic Drug Revenue 2018-2034
1.4.2 Global Oncology Therapeutic Drug Sales 2018-2034
1.4.3 Global Oncology Therapeutic Drug Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Oncology Therapeutic Drug Market Competition by Manufacturers
2.1 Global Oncology Therapeutic Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oncology Therapeutic Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oncology Therapeutic Drug Average Price by Manufacturers (2018-2023)
2.4 Global Oncology Therapeutic Drug Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Oncology Therapeutic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology Therapeutic Drug, Product Type & Application
2.7 Oncology Therapeutic Drug Market Competitive Situation and Trends
2.7.1 Oncology Therapeutic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oncology Therapeutic Drug Players Market Share by Revenue
2.7.3 Global Oncology Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Therapeutic Drug Retrospective Market Scenario by Region
3.1 Global Oncology Therapeutic Drug Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Oncology Therapeutic Drug Global Oncology Therapeutic Drug Sales by Region: 2018-2034
3.2.1 Global Oncology Therapeutic Drug Sales by Region: 2018-2023
3.2.2 Global Oncology Therapeutic Drug Sales by Region: 2024-2034
3.3 Global Oncology Therapeutic Drug Global Oncology Therapeutic Drug Revenue by Region: 2018-2034
3.3.1 Global Oncology Therapeutic Drug Revenue by Region: 2018-2023
3.3.2 Global Oncology Therapeutic Drug Revenue by Region: 2024-2034
3.4 North America Oncology Therapeutic Drug Market Facts & Figures by Country
3.4.1 North America Oncology Therapeutic Drug Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Oncology Therapeutic Drug Sales by Country (2018-2034)
3.4.3 North America Oncology Therapeutic Drug Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oncology Therapeutic Drug Market Facts & Figures by Country
3.5.1 Europe Oncology Therapeutic Drug Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Oncology Therapeutic Drug Sales by Country (2018-2034)
3.5.3 Europe Oncology Therapeutic Drug Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology Therapeutic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Oncology Therapeutic Drug Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Oncology Therapeutic Drug Sales by Country (2018-2034)
3.6.3 Asia Pacific Oncology Therapeutic Drug Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oncology Therapeutic Drug Market Facts & Figures by Country
3.7.1 Latin America Oncology Therapeutic Drug Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Oncology Therapeutic Drug Sales by Country (2018-2034)
3.7.3 Latin America Oncology Therapeutic Drug Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncology Therapeutic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology Therapeutic Drug Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Oncology Therapeutic Drug Sales by Country (2018-2034)
3.8.3 Middle East and Africa Oncology Therapeutic Drug Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oncology Therapeutic Drug Sales by Type (2018-2034)
4.1.1 Global Oncology Therapeutic Drug Sales by Type (2018-2023)
4.1.2 Global Oncology Therapeutic Drug Sales by Type (2024-2034)
4.1.3 Global Oncology Therapeutic Drug Sales Market Share by Type (2018-2034)
4.2 Global Oncology Therapeutic Drug Revenue by Type (2018-2034)
4.2.1 Global Oncology Therapeutic Drug Revenue by Type (2018-2023)
4.2.2 Global Oncology Therapeutic Drug Revenue by Type (2024-2034)
4.2.3 Global Oncology Therapeutic Drug Revenue Market Share by Type (2018-2034)
4.3 Global Oncology Therapeutic Drug Price by Type (2018-2034)
5 Segment by Application
5.1 Global Oncology Therapeutic Drug Sales by Application (2018-2034)
5.1.1 Global Oncology Therapeutic Drug Sales by Application (2018-2023)
5.1.2 Global Oncology Therapeutic Drug Sales by Application (2024-2034)
5.1.3 Global Oncology Therapeutic Drug Sales Market Share by Application (2018-2034)
5.2 Global Oncology Therapeutic Drug Revenue by Application (2018-2034)
5.2.1 Global Oncology Therapeutic Drug Revenue by Application (2018-2023)
5.2.2 Global Oncology Therapeutic Drug Revenue by Application (2024-2034)
5.2.3 Global Oncology Therapeutic Drug Revenue Market Share by Application (2018-2034)
5.3 Global Oncology Therapeutic Drug Price by Application (2018-2034)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Oncology Therapeutic Drug Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Corporation Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Oncology Therapeutic Drug Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Astellas Pharma
6.3.1 Astellas Pharma Corporation Information
6.3.2 Astellas Pharma Description and Business Overview
6.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Astellas Pharma Oncology Therapeutic Drug Product Portfolio
6.3.5 Astellas Pharma Recent Developments/Updates
6.4 AstraZeneca
6.4.1 AstraZeneca Corporation Information
6.4.2 AstraZeneca Description and Business Overview
6.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 AstraZeneca Oncology Therapeutic Drug Product Portfolio
6.4.5 AstraZeneca Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bayer Oncology Therapeutic Drug Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Biogen
6.6.1 Biogen Corporation Information
6.6.2 Biogen Description and Business Overview
6.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Biogen Oncology Therapeutic Drug Product Portfolio
6.6.5 Biogen Recent Developments/Updates
6.7 Bristol Myers Squibb
6.6.1 Bristol Myers Squibb Corporation Information
6.6.2 Bristol Myers Squibb Description and Business Overview
6.6.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol Myers Squibb Oncology Therapeutic Drug Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Celgene
6.8.1 Celgene Corporation Information
6.8.2 Celgene Description and Business Overview
6.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Celgene Oncology Therapeutic Drug Product Portfolio
6.8.5 Celgene Recent Developments/Updates
6.9 Eisai
6.9.1 Eisai Corporation Information
6.9.2 Eisai Description and Business Overview
6.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Eisai Oncology Therapeutic Drug Product Portfolio
6.9.5 Eisai Recent Developments/Updates
6.10 Eli Lilly and Company
6.10.1 Eli Lilly and Company Corporation Information
6.10.2 Eli Lilly and Company Description and Business Overview
6.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Eli Lilly and Company Oncology Therapeutic Drug Product Portfolio
6.10.5 Eli Lilly and Company Recent Developments/Updates
6.11 Gilead Sciences
6.11.1 Gilead Sciences Corporation Information
6.11.2 Gilead Sciences Oncology Therapeutic Drug Description and Business Overview
6.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Gilead Sciences Oncology Therapeutic Drug Product Portfolio
6.11.5 Gilead Sciences Recent Developments/Updates
6.12 Ipsen
6.12.1 Ipsen Corporation Information
6.12.2 Ipsen Oncology Therapeutic Drug Description and Business Overview
6.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Ipsen Oncology Therapeutic Drug Product Portfolio
6.12.5 Ipsen Recent Developments/Updates
6.13 Johnson and Johnson
6.13.1 Johnson and Johnson Corporation Information
6.13.2 Johnson and Johnson Oncology Therapeutic Drug Description and Business Overview
6.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Johnson and Johnson Oncology Therapeutic Drug Product Portfolio
6.13.5 Johnson and Johnson Recent Developments/Updates
6.14 Merck
6.14.1 Merck Corporation Information
6.14.2 Merck Oncology Therapeutic Drug Description and Business Overview
6.14.3 Merck Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Merck Oncology Therapeutic Drug Product Portfolio
6.14.5 Merck Recent Developments/Updates
6.15 Novartis
6.15.1 Novartis Corporation Information
6.15.2 Novartis Oncology Therapeutic Drug Description and Business Overview
6.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Novartis Oncology Therapeutic Drug Product Portfolio
6.15.5 Novartis Recent Developments/Updates
6.16 Otsuka Pharmaceutical
6.16.1 Otsuka Pharmaceutical Corporation Information
6.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Description and Business Overview
6.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Portfolio
6.16.5 Otsuka Pharmaceutical Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Oncology Therapeutic Drug Description and Business Overview
6.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Pfizer Oncology Therapeutic Drug Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
6.18 F. Hoffmann-La Roche
6.18.1 F. Hoffmann-La Roche Corporation Information
6.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Description and Business Overview
6.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Portfolio
6.18.5 F. Hoffmann-La Roche Recent Developments/Updates
6.19 Sanofi
6.19.1 Sanofi Corporation Information
6.19.2 Sanofi Oncology Therapeutic Drug Description and Business Overview
6.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Sanofi Oncology Therapeutic Drug Product Portfolio
6.19.5 Sanofi Recent Developments/Updates
6.20 Takeda Pharmaceutical
6.20.1 Takeda Pharmaceutical Corporation Information
6.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Description and Business Overview
6.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Product Portfolio
6.20.5 Takeda Pharmaceutical Recent Developments/Updates
6.21 Teva Pharmaceutical Industries
6.21.1 Teva Pharmaceutical Industries Corporation Information
6.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Description and Business Overview
6.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Portfolio
6.21.5 Teva Pharmaceutical Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology Therapeutic Drug Industry Chain Analysis
7.2 Oncology Therapeutic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology Therapeutic Drug Production Mode & Process
7.4 Oncology Therapeutic Drug Sales and Marketing
7.4.1 Oncology Therapeutic Drug Sales Channels
7.4.2 Oncology Therapeutic Drug Distributors
7.5 Oncology Therapeutic Drug Customers
8 Oncology Therapeutic Drug Market Dynamics
8.1 Oncology Therapeutic Drug Industry Trends
8.2 Oncology Therapeutic Drug Market Drivers
8.3 Oncology Therapeutic Drug Market Challenges
8.4 Oncology Therapeutic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Oncology Therapeutic Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Oncology Therapeutic Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Oncology Therapeutic Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Oncology Therapeutic Drug Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Oncology Therapeutic Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Oncology Therapeutic Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Oncology Therapeutic Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Oncology Therapeutic Drug Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Oncology Therapeutic Drug, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Oncology Therapeutic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oncology Therapeutic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Oncology Therapeutic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncology Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Therapeutic Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology Therapeutic Drug Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Oncology Therapeutic Drug Sales by Region (2018-2023) & (K Units)
Table 18. Global Oncology Therapeutic Drug Sales Market Share by Region (2018-2023)
Table 19. Global Oncology Therapeutic Drug Sales by Region (2024-2034) & (K Units)
Table 20. Global Oncology Therapeutic Drug Sales Market Share by Region (2024-2034)
Table 21. Global Oncology Therapeutic Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Oncology Therapeutic Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Oncology Therapeutic Drug Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Oncology Therapeutic Drug Revenue Market Share by Region (2024-2034)
Table 25. North America Oncology Therapeutic Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 27. North America Oncology Therapeutic Drug Sales by Country (2024-2034) & (K Units)
Table 28. North America Oncology Therapeutic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Oncology Therapeutic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Oncology Therapeutic Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 32. Europe Oncology Therapeutic Drug Sales by Country (2024-2034) & (K Units)
Table 33. Europe Oncology Therapeutic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Oncology Therapeutic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Oncology Therapeutic Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Oncology Therapeutic Drug Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Oncology Therapeutic Drug Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Oncology Therapeutic Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Oncology Therapeutic Drug Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Oncology Therapeutic Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Oncology Therapeutic Drug Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Oncology Therapeutic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oncology Therapeutic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Oncology Therapeutic Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Oncology Therapeutic Drug Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Oncology Therapeutic Drug Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Oncology Therapeutic Drug Sales (K Units) by Type (2018-2023)
Table 51. Global Oncology Therapeutic Drug Sales (K Units) by Type (2024-2034)
Table 52. Global Oncology Therapeutic Drug Sales Market Share by Type (2018-2023)
Table 53. Global Oncology Therapeutic Drug Sales Market Share by Type (2024-2034)
Table 54. Global Oncology Therapeutic Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Oncology Therapeutic Drug Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Oncology Therapeutic Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Oncology Therapeutic Drug Revenue Market Share by Type (2024-2034)
Table 58. Global Oncology Therapeutic Drug Price (US$/Unit) by Type (2018-2023)
Table 59. Global Oncology Therapeutic Drug Price (US$/Unit) by Type (2024-2034)
Table 60. Global Oncology Therapeutic Drug Sales (K Units) by Application (2018-2023)
Table 61. Global Oncology Therapeutic Drug Sales (K Units) by Application (2024-2034)
Table 62. Global Oncology Therapeutic Drug Sales Market Share by Application (2018-2023)
Table 63. Global Oncology Therapeutic Drug Sales Market Share by Application (2024-2034)
Table 64. Global Oncology Therapeutic Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Oncology Therapeutic Drug Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Oncology Therapeutic Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Oncology Therapeutic Drug Revenue Market Share by Application (2024-2034)
Table 68. Global Oncology Therapeutic Drug Price (US$/Unit) by Application (2018-2023)
Table 69. Global Oncology Therapeutic Drug Price (US$/Unit) by Application (2024-2034)
Table 70. AbbVie Corporation Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AbbVie Oncology Therapeutic Drug Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Amgen Oncology Therapeutic Drug Product
Table 79. Amgen Recent Developments/Updates
Table 80. Astellas Pharma Corporation Information
Table 81. Astellas Pharma Description and Business Overview
Table 82. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Astellas Pharma Oncology Therapeutic Drug Product
Table 84. Astellas Pharma Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. AstraZeneca Oncology Therapeutic Drug Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Bayer Oncology Therapeutic Drug Product
Table 94. Bayer Recent Developments/Updates
Table 95. Biogen Corporation Information
Table 96. Biogen Description and Business Overview
Table 97. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Biogen Oncology Therapeutic Drug Product
Table 99. Biogen Recent Developments/Updates
Table 100. Bristol Myers Squibb Corporation Information
Table 101. Bristol Myers Squibb Description and Business Overview
Table 102. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Bristol Myers Squibb Oncology Therapeutic Drug Product
Table 104. Bristol Myers Squibb Recent Developments/Updates
Table 105. Celgene Corporation Information
Table 106. Celgene Description and Business Overview
Table 107. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Celgene Oncology Therapeutic Drug Product
Table 109. Celgene Recent Developments/Updates
Table 110. Eisai Corporation Information
Table 111. Eisai Description and Business Overview
Table 112. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Eisai Oncology Therapeutic Drug Product
Table 114. Eisai Recent Developments/Updates
Table 115. Eli Lilly and Company Corporation Information
Table 116. Eli Lilly and Company Description and Business Overview
Table 117. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Eli Lilly and Company Oncology Therapeutic Drug Product
Table 119. Eli Lilly and Company Recent Developments/Updates
Table 120. Gilead Sciences Corporation Information
Table 121. Gilead Sciences Description and Business Overview
Table 122. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Gilead Sciences Oncology Therapeutic Drug Product
Table 124. Gilead Sciences Recent Developments/Updates
Table 125. Ipsen Corporation Information
Table 126. Ipsen Description and Business Overview
Table 127. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Ipsen Oncology Therapeutic Drug Product
Table 129. Ipsen Recent Developments/Updates
Table 130. Johnson and Johnson Corporation Information
Table 131. Johnson and Johnson Description and Business Overview
Table 132. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Johnson and Johnson Oncology Therapeutic Drug Product
Table 134. Johnson and Johnson Recent Developments/Updates
Table 135. Merck Corporation Information
Table 136. Merck Description and Business Overview
Table 137. Merck Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Merck Oncology Therapeutic Drug Product
Table 139. Merck Recent Developments/Updates
Table 140. Novartis Corporation Information
Table 141. Novartis Description and Business Overview
Table 142. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Novartis Oncology Therapeutic Drug Product
Table 144. Novartis Recent Developments/Updates
Table 145. Otsuka Pharmaceutical Corporation Information
Table 146. Otsuka Pharmaceutical Description and Business Overview
Table 147. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Otsuka Pharmaceutical Oncology Therapeutic Drug Product
Table 149. Otsuka Pharmaceutical Recent Developments/Updates
Table 150. Pfizer Corporation Information
Table 151. Pfizer Description and Business Overview
Table 152. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Pfizer Oncology Therapeutic Drug Product
Table 154. Pfizer Recent Developments/Updates
Table 155. F. Hoffmann-La Roche Corporation Information
Table 156. F. Hoffmann-La Roche Description and Business Overview
Table 157. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. F. Hoffmann-La Roche Oncology Therapeutic Drug Product
Table 159. F. Hoffmann-La Roche Recent Developments/Updates
Table 160. Sanofi Corporation Information
Table 161. Sanofi Description and Business Overview
Table 162. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Sanofi Oncology Therapeutic Drug Product
Table 164. Sanofi Recent Developments/Updates
Table 165. Takeda Pharmaceutical Corporation Information
Table 166. Takeda Pharmaceutical Description and Business Overview
Table 167. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. Takeda Pharmaceutical Oncology Therapeutic Drug Product
Table 169. Takeda Pharmaceutical Recent Developments/Updates
Table 170. Teva Pharmaceutical Industries Corporation Information
Table 171. Teva Pharmaceutical Industries Description and Business Overview
Table 172. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product
Table 174. Teva Pharmaceutical Industries Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Oncology Therapeutic Drug Distributors List
Table 178. Oncology Therapeutic Drug Customers List
Table 179. Oncology Therapeutic Drug Market Trends
Table 180. Oncology Therapeutic Drug Market Drivers
Table 181. Oncology Therapeutic Drug Market Challenges
Table 182. Oncology Therapeutic Drug Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oncology Therapeutic Drug
Figure 2. Global Oncology Therapeutic Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Oncology Therapeutic Drug Market Share by Type in 2024 & 2034
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Therapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Hormonal Therapy Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oncology Therapeutic Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Oncology Therapeutic Drug Market Share by Application in 2024 & 2034
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory and Lung Cancer
Figure 15. Others
Figure 16. Global Oncology Therapeutic Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Oncology Therapeutic Drug Market Size (2018-2034) & (US$ Million)
Figure 18. Global Oncology Therapeutic Drug Sales (2018-2034) & (K Units)
Figure 19. Global Oncology Therapeutic Drug Average Price (US$/Unit) & (2018-2034)
Figure 20. Oncology Therapeutic Drug Report Years Considered
Figure 21. Oncology Therapeutic Drug Sales Share by Manufacturers in 2024
Figure 22. Global Oncology Therapeutic Drug Revenue Share by Manufacturers in 2024
Figure 23. The Global 5 and 10 Largest Oncology Therapeutic Drug Players: Market Share by Revenue in 2024
Figure 24. Oncology Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 25. Global Oncology Therapeutic Drug Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 26. North America Oncology Therapeutic Drug Sales Market Share by Country (2018-2034)
Figure 27. North America Oncology Therapeutic Drug Revenue Market Share by Country (2018-2034)
Figure 28. United States Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Canada Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Europe Oncology Therapeutic Drug Sales Market Share by Country (2018-2034)
Figure 31. Europe Oncology Therapeutic Drug Revenue Market Share by Country (2018-2034)
Figure 32. Germany Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. France Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. U.K. Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Italy Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Russia Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Asia Pacific Oncology Therapeutic Drug Sales Market Share by Region (2018-2034)
Figure 38. Asia Pacific Oncology Therapeutic Drug Revenue Market Share by Region (2018-2034)
Figure 39. China Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Japan Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. South Korea Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. India Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Australia Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. China Taiwan Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Indonesia Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Thailand Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Malaysia Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Latin America Oncology Therapeutic Drug Sales Market Share by Country (2018-2034)
Figure 49. Latin America Oncology Therapeutic Drug Revenue Market Share by Country (2018-2034)
Figure 50. Mexico Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Brazil Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Argentina Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country (2018-2034)
Figure 54. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country (2018-2034)
Figure 55. Turkey Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. UAE Oncology Therapeutic Drug Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 58. Global Sales Market Share of Oncology Therapeutic Drug by Type (2018-2034)
Figure 59. Global Revenue Market Share of Oncology Therapeutic Drug by Type (2018-2034)
Figure 60. Global Oncology Therapeutic Drug Price (US$/Unit) by Type (2018-2034)
Figure 61. Global Sales Market Share of Oncology Therapeutic Drug by Application (2018-2034)
Figure 62. Global Revenue Market Share of Oncology Therapeutic Drug by Application (2018-2034)
Figure 63. Global Oncology Therapeutic Drug Price (US$/Unit) by Application (2018-2034)
Figure 64. Oncology Therapeutic Drug Value Chain
Figure 65. Oncology Therapeutic Drug Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed